Syndax Pharmaceuticals Inc (NAS:SNDX)
$ 19.69 0.75 (3.96%) Market Cap: 1.68 Bil Enterprise Value: 1.18 Bil PE Ratio: 0 PB Ratio: 3.85 GF Score: 41/100

Syndax Pharmaceuticals Inc Annual Shareholders Meeting Transcript

Jun 09, 2020 / 12:30PM GMT
Release Date Price: $17.02 (+0.18%)
Operator

Hello and welcome to the 2020 Annual Meeting of Stockholders of Syndax Pharmaceuticals, Inc. Please note that today's meeting is being recorded. After the meeting, we will have a question-and-answer session. (Operator Instructions) Shareholders entering the meeting webcast with a control number can submit questions or comments at any time by clicking on the Message icon.

It is now my pleasure to turn today's meeting over to Dr. Briggs Morrison, Chief Executive Officer of Syndax. Dr. Morrison, the floor is yours.

Briggs W. Morrison
Syndax Pharmaceuticals, Inc. - CEO & Director

Good morning. I'm Briggs Morrison, and I'm the CEO of Syndax Pharmaceuticals. I'm very happy to welcome you to the Syndax Pharmaceuticals 2020 Stockholders' Meeting. Before I call the meeting to order, I'd like to introduce you to the members of the Board and the business team who are with us today. The other members of the Board are Dennis Podlesak, Chairman; Fabrice Egros; Jennifer Jarrett; Keith Katkin, Pierre Legault; Michael Metzger, who is also our President and Chief

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot